Clinical Trial Update: Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is described evaluating All-trans Retinoic Acid with paclitaxel and cisplatin as first-line therapy for advanced non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN